This past winter, hospitals and clinics across Indiana filled up with patients suffering from different respiratory illnesses that have much the same symptoms: COVID-19, flu and RSV. And many more ...

Roche Diagnostics says it has developed blood tests to help rule out a diagnosis of Alzheimer’s disease in the broad population, thus narrowing who might be suffering from the disease. Nearly 7 ...

BGI Genomics and Roche Diagnostics have rolled out tests for Alzheimer's disease in China, the companies said, in an effort ...

Used with the cobas ® 5800, 6800 and 8800 systems, cobas Respiratory 4-flex simultaneously detects and differentiates the four most common respiratory viruses, helping to ensure confidence in ...

Rules out Alzheimer's pathology in early stages to enhance diagnostic pathway efficiency Provides new opportunity to broaden access and improve referral quality Features as part of Roche's growing ...

Switzerland-based Roche this week said it has received U.S. regulatory clearance for an Alzheimer’s blood test. This test is used in primary care offices for a patient’s initial assessment of ...

Roche says it's actively working with its partners to enhance mpox laboratory capacity worldwide to develop diagnostic tests to combat the outbreak. The World Health Organization (WHO) last week ...

Roche has entered into a U.S.-focused collaboration with Pfizer to drive awareness and educate on the importance of timely COVID-19 testing, available treatment options, symptoms and the high-risk ...

Basel, 6 December 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced its plans to launch the SARS-CoV-2 & Flu A/B Rapid Antigen Test for professional use in markets accepting the CE Mark by the ...

ZURICH (Reuters) - Roche has struck a $1.7 billion cancer drug pact with Blueprint Medicines , it said on Tuesday, as advances in genetic testing for rare mutations drive lucrative deals for expensive ...